Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...

Buzz on the Bullboards: Early Movers in Health, Mining and Tech

By the second week of the year, people, businesses and even the stock market are back to business as usual following the holiday rush in December and ringing in the new year in early January. Discussions on our Stockhouse Bullboards are also back in the saddle, and co...

U.S.-Based Biotech 'Growing into a Giant with AI'

How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report. In a March 5 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that a site visit to Moderna Inc.'s (MRNA:NASDAQ) ...

No Investment Pays off more than Education

(Image via Ivanhoe Mines Ltd.) “You miss 100% of the shots you don’t take.” - Wayne Gretzky (or Michael Scott) It has been a busy week for markets and investors alike, with the COVID-19 vaccine rollout, US election ...

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses

Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. Clinical-stage immuno...

Europe is Serious about Raw Materials for its Green Transition, so is This Junior Miner

(Map of Leading Edge Materials Corp.’s European projects and IEA estimated growth in demand for graphite and rare earth elements from clean energy technologies in 2040 relative to 2020 levels). Image via Leading Edge Materials Corp. Click to enlarge.) ...

Buzz on the Bullboards: One Step Closer to a Canadian-Made COVID Vaccine?

(Image via Theralase Technologies Inc.) Clinical-stage pharmaceutical company Theralase Technologies Inc. ( TSX-V: TLT , Forum ) has demonstrated proof-of-concept for its Canadian-made COVID-19 vaccine. In collaboration with the University of Manitoba (UM), t...

Buzz on the Bullboards: Crisis Creates Opportunity

As November draws to a close, many investors may take time to consider what they are thankful for. Even if the American Thanksgiving isn’t something you celebrate, there are a lot of reasons to be thankful these days, from having our health, to major stock...

For Better or Worse? On the Verge of a New Era in Investing

(The Global 7500 aircraft. Image via Bombardier Inc.) If there is one thing that we have learned one year into the COVID-19 pandemic, we must often take things as they come, week by week, especially in a volatile market. It's no April Fool's prank. Each week, w...
1 2 3 4 5 6 7 8 9 10 ...